Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling

Hypermutable Pseudomonas aeruginosa strains have a greatly increased mutation rate and are prevalent in chronic respiratory infections. Initially, we systematically evaluated the time-course of total and resistant populations of hypermutable (PAO∆mutS) and non-hypermutable (PAO1) P. aeruginosa strai...

Descripción completa

Detalles Bibliográficos
Autores principales: Rees, Vanessa E., Bulitta, Jürgen B., Oliver, Antonio, Nation, Roger L., Landersdorfer, Cornelia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781503/
https://www.ncbi.nlm.nih.gov/pubmed/31547301
http://dx.doi.org/10.3390/pharmaceutics11090470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781503/
https://www.ncbi.nlm.nih.gov/pubmed/31547301
http://dx.doi.org/10.3390/pharmaceutics11090470

Ejemplares similares